Aimovig and Requip drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Aimovig (erenumab-aooe) and Requip (ropinirole hydrochloride). Common drug interactions include disability among females and confusional state among males.

The phase IV clinical study analyzes what interactions people have when they take Aimovig and Requip. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Aimovig?

Aimovig has active ingredients of erenumab-aooe. eHealthMe is studying from 49,930 Aimovig users. Check the latest studies of Aimovig.

What is Requip?

Requip has active ingredients of ropinirole hydrochloride. It is often used in restless leg syndrome. eHealthMe is studying from 22,950 Requip users. Check the latest studies of Requip.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

25 people who take Aimovig and Requip together, and have interactions are studied.

What are the common drug interactions of Aimovig and Requip, by gender? *:

female:

Disability
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Nausea (feeling of having an urge to vomit)
Tremor (trembling or shaking movements in one or more parts of your body)
Anxiety
Blood pressure increased
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Dyskinesia (abnormality or impairment of voluntary movement)
Fatigue (feeling of tiredness)

male:

Confusional state
Fatigue (feeling of tiredness)
Suicidal ideation
Cardiac arrest
Exposure to communicable disease
Memory impairment
Migraine (headache)
Muscle spasms (muscle contraction)
Pain
Seizure (abnormal excessive or synchronous neuronal activity in the brain)

What are the common drug interactions of Aimovig and Requip, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Depression
Generalised anxiety disorder (excessive, uncontrollable, unexplained and often irrational worry)
Suicidal ideation
Encephalitis (inflammation of the brain)
Lyme disease (a bacterial infection that is spread to humans by infected ticks)
Spinal disorder (disease of spine a back bone)

40-49:

Abnormal dreams
Alopecia (absence of hair from areas of the body)
Anxiety
Arthralgia (joint pain)
Disability
Fatigue (feeling of tiredness)
Flushing (the warm, red condition of human skin)
Headache (pain in head)
Hypoaesthesia (reduced sense of touch or sensation)
Lower limb fracture

50-59:

Depression
Dizziness
Dysphonia (speech disorder attributable to a disorder of phonation)
Fatigue (feeling of tiredness)
Immunosuppression
Insomnia (sleeplessness)
Joint stiffness
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Muscle spasms (muscle contraction)

60+:

Cardiac arrest
Insomnia (sleeplessness)

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 11 people, 44.00%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 11 people, 44.00%
Migraine (headache): 8 people, 32.00%
Drowsiness: 4 people, 16.00%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 2 people, 8.00%
Nausea (feeling of having an urge to vomit): 2 people, 8.00%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 8.00%
Headache (pain in head): 2 people, 8.00%
Diabetes: 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Aimovig and Requip?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously